Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Mori (Seto, Japan), Y. Yamano (Seto, Japan), T. Yokoyama (Seto, Japan), T. Matsuda (Seto, Japan), K. Kataoka (Seto, Japan), T. Kimura (Seto, Japan), Y. Kondoh (Seto, Japan). The health status in idiopathic pleuroparenchymal fibroelastosis. 1315

Member's Comments

No comment yet.

Related content which might interest you: Clinical courses of asymptomatic patients with mild idiopathic pleuroparenchymal fibroelastosis Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Treatment with nintedanib in patients with pleuroparenchymal fibroelastosis Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Predicting factors for mortality in patients with pleuroparenchymal fibroelastosis Source: International Congress 2017 – Rare diseases Year: 2017 Clinical and pathological features of idiopathic and secondary pleuroparenchymal fibroelastosis in patients undergoing lung transplantation Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection? Source: Eur Respir J 2013; 41: 243-245 Year: 2013 Prognostic and clinical value of cluster analysis of idiopathic pleuroparenchymal fibroelastosis phenotypes Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia Year: 2019 Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Architectural remodelling in idiopathic interstitial pneumonias: fibrosis or fibroelastosis? Source: Eur Respir J 2004; 24: Suppl. 48, 557s Year: 2004 Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes Source: Eur Respir J 2012; 40: 377-385 Year: 2012 Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia Source: ERJ Open Res, 7 (1) 00196-2020; 10.1183/23120541.00196-2020 Year: 2021 Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity? Source: Eur Respir J 2015; 45: 1183-1186 Year: 2015 Bullous emphysema in adolescent: is congenital malformation or outcome of bronchopulmonary dysplasia? Source: International Congress 2019 – Paediatric respiratory diseases Year: 2019 Never-smoking history as a poor prognostic factor in surgically proven idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Air-leak syndrome caused by pleuroparenchymal fibroelastosis after bone marrow transplantation Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Clinical features of patients with idiopathic pulmonary upper lobe-dominant fibrosis Source: International Congress 2016 – Orphan diseases I Year: 2016 Idiopathic hyperventilation impairs health status Source: Eur Respir J 2003; 22: Suppl. 45, 442s Year: 2003 Pleuroparenchymal fibroelastosis - clinical analysis of 22 cases Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 A rare case of idiopathic pulmonary fibrosis in children Source: Eur Respir J 2007; 30: Suppl. 51, 390s Year: 2007 The thoracic cage becomes flattened in the progression of pleuroparenchymal fibroelastosis Source: Eur Respir Rev 2014; 23:263-266 Year: 2014 Idiopathic pulmonary fibrosis: does smoking status influence outcome? Source: Eur Respir J 2006; 28: Suppl. 50, 830s Year: 2006